BACKGROUND: The incidence of pertussis in adults is high despite good childhood
vaccination coverage. An adult formulation of an acellular pertussis vaccine is licensed and …

The aim of the current study is to estimate the epidemiological and economical
consequences of several extended pertussis booster vaccination strategies and to explore …

Acellular pertussis vaccines are less reactogenic than whole cell pertussis vaccines, but
they are also more expensive. Based on simulation models, we compared the costs and …

To reduce pertussis disease burden new vaccination strategies are considered in many
countries. Since not only health benefits, but also economical aspects play a role when …

Background Pertussis vaccination for risk-groups (eg healthcare workers, employees of
communal facilities, or persons with close contact to infants) has been recommended in …

The aim of this study was to investigate the optimal pertussis booster vaccination strategy for
The Netherlands. A realistic age-structured deterministic model was designed. Assuming a …

Background Despite widespread immunization programs, a clear increase in pertussis
incidence is apparent in many developed countries during the last decades. Consequently …

Background. The incidence of reported pertussis among adolescents, adults, and young
infants has increased sharply over the past decade. Combined acellular pertussis vaccines …

Background The acellular pertussis vaccine has been used in the Norwegian national
immunisation program since 1998. Following an increase in pertussis incidence in all age …

An economic evaluation was performed of universal acellular pertussis vaccination in Italy,
where until recently the overall coverage of pertussis vaccination was estimated at 50 …